IPP Bureau
Telemedicine service eSanjeevani achieves 8 crore teleconsultations
By IPP Bureau - December 07, 2022
The initiative has garnered the distinction of being the world’s largest government owned telemedicine platform
Briefs: Natco Pharma & Lupin
By IPP Bureau - December 06, 2022
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Apollo Conclave 2022 highlights role of research in driving better clinical outcomes
By IPP Bureau - December 06, 2022
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Biocon Biologics elevates Shreehas Tambe as MD & CEO
By IPP Bureau - December 06, 2022
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
BASF Pharma Solutions excipient accepted into FDA Pilot Program
By IPP Bureau - December 06, 2022
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
JB Pharma reduces price of Azmarda by 50%
By IPP Bureau - December 06, 2022
Move to increase affordability and accessibility for heart failure patients across the country
Indira IVF to offer fertility perks for Indian corporate employees
By IPP Bureau - December 06, 2022
The service includes full fertility care benefits, including egg and embryo freezing options to employees
ANSSI Wellness inaugurates its new spine clinic in Pune
By IPP Bureau - December 06, 2022
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
ASG Eye Hospitals opens hospital in Vashi
By IPP Bureau - December 06, 2022
The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra
Auretics launched herbal cough syrup ‘Sedoril’
By IPP Bureau - December 06, 2022
It offers quick relief in various types of Coughs, Colds and Sore Throat,
Lonza’s API manufacturing facility expansion in Nansha starts commercial operation
By IPP Bureau - December 06, 2022
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
Agilent opens customer experience center for genomics and diagnostics solutions
By IPP Bureau - December 06, 2022
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Zydus receives final approval from USFDA for Estradiol Transdermal System
By IPP Bureau - December 05, 2022
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Mirati Therapeutics announces update for the Phase 3 SAPPHIRE study
By IPP Bureau - December 05, 2022
Evaluating Investigational Sitravatinib in combination with Nivolumab for patients with non-squamous non-small cell lung cancer
Valneva and Pfizer report antibody persistence data for lyme disease vaccine candidate
By IPP Bureau - December 05, 2022
Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule
